ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Concomitant disease aggravated | 08.01.03.063 | 0.002461% | | Not Available |
Congenital umbilical hernia | 07.16.03.003; 03.04.07.006 | 0.001230% | | Not Available |
Full blood count decreased | 13.01.07.004 | - | - | Not Available |
Hilar lymphadenopathy | 22.09.03.005; 01.09.01.023 | 0.001230% | | Not Available |
Lymphadenopathy mediastinal | 22.09.03.006; 01.09.01.025 | 0.001846% | | Not Available |
Malignant ascites | 16.32.03.013; 07.07.01.004 | 0.000321% | | Not Available |
Malignant pleural effusion | 16.32.03.014; 22.05.04.001 | 0.000802% | | Not Available |
Metastases to bone | 16.22.02.005; 15.09.03.006 | 0.007383% | | Not Available |
Metastases to kidney | 20.01.04.010; 16.22.02.017 | 0.000321% | | Not Available |
Metastases to lymph nodes | 16.22.02.006; 01.09.01.015 | 0.002247% | | Not Available |
Metastases to pleura | 22.05.04.002; 16.22.02.022 | 0.000321% | | Not Available |
Metastases to skin | 16.22.02.023; 23.07.04.026 | 0.003691% | | Not Available |
Metastases to the mediastinum | 22.09.03.009; 16.22.02.027 | 0.001230% | | Not Available |
Portal shunt | 09.01.06.023; 24.08.06.007 | 0.000802% | | Not Available |
Purulent discharge | 11.01.08.061; 08.01.03.076 | 0.001846% | | Not Available |
Recurrent cancer | 16.16.01.015 | 0.002461% | | Not Available |
Systemic sclerosis | 07.11.02.008; 24.03.03.041; 23.03.02.021; 15.06.01.019; 10.04.07.006 | 0.000642% | | Not Available |
Toxic nodular goitre | 05.02.02.007; 14.11.01.047 | 0.001230% | | Not Available |
Brain malformation | 17.19.01.008; 03.10.02.008 | 0.001230% | | Not Available |
Tumour marker increased | 13.22.01.017 | 0.006152% | | Not Available |
Concomitant disease progression | 08.01.03.064 | 0.000481% | | Not Available |
Subclavian vein thrombosis | 24.01.02.013 | 0.001230% | | Not Available |
Live birth | 18.08.02.007 | 0.001230% | | Not Available |
Carbohydrate antigen 15-3 increased | 13.22.01.006 | 0.002461% | | Not Available |
Primary sequestrum | 15.02.04.038 | 0.001230% | | Not Available |
Lymphangiosis carcinomatosa | 16.22.02.009; 01.09.01.027; 24.09.02.007 | 0.000321% | | Not Available |
Bone swelling | 15.02.01.006 | 0.001230% | | Not Available |
Congenital cerebral cyst | 03.10.03.003; 17.18.05.003; 16.09.05.003 | 0.000481% | | Not Available |
Breast cancer metastatic | 21.05.01.016; 16.10.01.008 | 0.005296% | | Not Available |
Tenosynovitis stenosans | 15.04.02.005 | 0.000802% | | Not Available |